Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Composition for relieving depression and preparation method and application thereof

A composition and technology for depression, which are applied in the field of compositions for relieving depression and its preparation, can solve problems such as poor effect, medication for people who cannot reduce depression, and complex ingredients, so as to accelerate the regeneration of brain nerve cells and improve cell regeneration. Oxygen supply and the effect of promoting nutrient absorption

Inactive Publication Date: 2019-04-16
HOBOOMLIFE BIO TECH SHENZHEN CO LTD
View PDF7 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The above-mentioned antidepressant western medicines have definite curative effects, but at the same time, there are also problems such as large toxic and side effects, easy drug dependence, and easy recurrence of the disease.
[0004] These chemical drugs have more or less unacceptable adverse reactions, and cannot be used for people with general depression
At present, there are also some Chinese patent medicine products on the domestic market, but most of them have the defects of poor effect or complex ingredients

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0028] The present embodiment provides a composition for relieving depression, which includes NADH, NADPH, ginsenoside PPD, ginsenoside Rh2, Lycium barbarum polysaccharide, polygala and active ingredients, the active ingredients are taurine, phosphatidylserine, cartilage sulfate at least one of ursodeoxycholic acid, sialic acid, s-adenosylmethionine, γ-aminobutyric acid, astaxanthin, and pyroglutamate.

[0029] The active ingredient can be taurine, phosphatidylserine, chondroitin sulfate, ursodeoxycholic acid, bird's nest acid, s-adenosylmethionine, γ-aminobutyric acid, astaxanthin, pyroglutamate One; or the active ingredient is taurine, phosphatidylserine, chondroitin sulfate, ursodeoxycholic acid, sulphate, s-adenosylmethionine, γ-aminobutyric acid, astaxanthin, pyroglutamic acid Several kinds of esters, preferably at least five, preferably at least four; preferably at least three, preferably at least two. Alternatively, the active ingredients include taurine, phosphatidyls...

Embodiment 2

[0037] This embodiment provides a composition for relieving depression, in parts by weight, the composition includes: 10 parts of NADH, 1 part of NADPH, 10 parts of ginsenoside PPD, 1 part of ginsenoside Rh2, 10 parts of Lycium barbarum polysaccharide, polygala 1 part, 7 parts of phosphatidylserine, 3 parts of chondroitin sulfate, the composition is prepared by the method described in Example 1.

[0038] This embodiment also provides a kind of pharmaceutical preparation, described pharmaceutical preparation comprises described composition and auxiliary material, and described auxiliary material comprises 3 parts of paraben complex esters, 4 parts of fumaric acid, 3 parts of xylitol in parts by weight . In this embodiment, the pharmaceutical preparation is a granule, which is prepared by the following method: pass the dried composition and auxiliary materials through a 60-mesh sieve, so that the particle size distribution is uniform and the fluidity is better. The composition a...

Embodiment 3

[0040] The present embodiment provides a composition for relieving depression. In parts by weight, the composition includes: 2.5 parts of NADH, 8 parts of NADPH, 2 parts of ginsenoside PPD, 9 parts of ginsenoside Rh2, 2 parts of Lycium barbarum polysaccharide, polygala 8 parts, 2 parts of active ingredient, described active ingredient comprises ursodeoxycholic acid, sialic acid, s-adenosylmethionine, γ-aminobutyric acid, astaxanthin, and the mass ratio of each component in described active ingredient is 1:2:2:1:2. The composition was prepared using the method described in Example 1.

[0041] This embodiment also provides a kind of pharmaceutical preparation, described pharmaceutical preparation comprises described composition and auxiliary material, and the weight portion of described auxiliary material is 7 parts, and described auxiliary material comprises xylitol, sorbitan fatty acid ester, stearin magnesium hydroxide, croscarmellose sodium, magnesium hydroxide, pregelatini...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to the technical field of health-care products, and discloses a composition for relieving depression and a preparation method and application thereof. The composition comprises NADH, NADPH, ginsenoside PPD, ginsenoside Rh2, medlar polysaccharide, polygala tenuifolia and active ingredients, wherein the active ingredients comprise at least one of taurine and phosphatidylserine;chondroitin sulfate, ursodeoxycholic acid, cubilic acid, s-adenosylmethionine, Gamma-aminobutyric acid, astaxanthin and pyroglutamate. The components play a synergistic role to provide an omnibearingand multi-link health-care composition for relieving depression, and the composition can improve the cell oxygen supply, accelerate the regeneration of brain nerve cells, promote the absorption of nutrients by the brain, regulate the secretion balance of the antidepressant hormone, and has obvious treatment effect on relieving depression; clinical observation shows that the treatment effect can reach more than 98%; and the original medicinal materials of the composition are plant medicaments, so that the optimal guarantee is provided for the safety of the composition.

Description

technical field [0001] The invention belongs to the technical field of health care products, and in particular relates to a composition for alleviating depression, a preparation method and application thereof. Background technique [0002] Depression, also known as depressive disorder, is characterized by significant and persistent depression as the main clinical feature. It is the main type of psychological disorder. In recent years, it has gradually become a common and frequent complication that endangers people's physical and mental health. It is estimated that there are 30 million patients with depression. Above, among people suffering from diseases such as high blood pressure, coronary heart disease, diabetes and even cancer, the incidence of depression is as high as 50%, and patients with severe depression have suicidal tendencies, which triggers a series of serious family and social problems. problems and economic loss. [0003] At present, antidepressant drugs are g...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/69A61P25/24A23L33/10A23L33/105A23L33/115A23L33/125A23L33/17A23L33/175A61K31/7084A61K31/704A61K31/715A61K31/185A61K31/685A61K31/737A61K31/575A61K31/7012A61K31/197A61K31/122A61K31/4015
CPCA23L33/10A23L33/105A23L33/115A23L33/125A23L33/17A23L33/175A23V2002/00A61K31/122A61K31/185A61K31/197A61K31/4015A61K31/575A61K31/685A61K31/7012A61K31/704A61K31/7084A61K31/715A61K31/737A61K36/69A61P25/24A61K2300/00A23V2200/322A23V2250/032A23V2250/038A23V2250/0644A23V2250/18A23V2250/1852A23V2250/2124A23V2250/312A23V2250/51A23V2250/5114A23V2250/5118A23V2250/5438A23V2250/616A23V2250/642
Inventor 陈建生李峰张波段志刚陈晓娟胡欢
Owner HOBOOMLIFE BIO TECH SHENZHEN CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com